| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing magnesium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Product containing magnesium alginate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachet sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium alginate (substance) |
Inferred relationship |
Some |
|
| Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Product containing magnesium alginate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Magnesium alginate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Magnesium alginate and sodium alginate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only magnesium alginate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium alginate (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]